NEUROLOGICAL FACTORS IN CFS / ME
1990
Extract from a press-conference held in
1991
Testing of Vestibular Function: An Adjunct in the Assessment of Chronic Syndrome. JMR Furman. Reviews of Infectious Diseases 1991:13 (Suppl 1):S10911
1994
A Comparative Review of Systemic and Neurological Symptomatology in 12 Outbreaks Collectively Described as Chronic Fatigue Syndrome, Epidemic Neuromyasthenia, and Myalgic Encephalomyelitis. NC Briggs, PH Levine. Clinical Infectious Diseases 1994:18 (Suppl 1):S32-42
Chronic Fatigue Syndrome Update - Findings Now Point To Central Nervous System Involvement. DS Bell. Postgraduate Medicine 1994:96:6:73-81
1995
Vestibular Function Test Anomalies in Patients with Chronic Fatigue Syndrome. R AshBernal, C Wall et al. Acta Otolaryngol (Stockh) 1995:115:9-17
1996
Decreased vagal power during treadmill walking in patients with chronic fatigue syndrome. DL Cordero, WN Tapp et al. Clinical Autonomic Research 1996:6:329-333
Medical Matters: Problems with Balance.
1997
Does the Chronic Fatigue Syndrome Involve the Autonomic Nervous System? R Freeman, MD Anthony, L Komaroff. The American Journal of Medicine 1997:102:357364
1998
Neurally Mediated Hypotension and Chronic Fatigue Syndrome. PC Rowe, H Calkins. The American Journal of Medicine 1998:105(3A):15S-21S
1999
Chronic Fatigue Syndrome is an Acquired Neurological Channelopathy. A Chaudhuri,
2000
Pall ML. 2000b. Elevated peroxynitrite as the cause of chronic fatigue syndrome:
Other inducers and mechanisms of symptom generation. J Chronic Fatigue Syndrome
7(4):45-58.
Pall ML. 2001b. Common etiology of posttraumatic stress disorder, fibromyalgia,
chronic fatigue syndrome and multiple chemical sensitivity via elevated nitric
oxide/peroxynitrite. Medical Hypoth 57:139-145.
Pall ML. 2002b. NMDA sensitization and stimulation by peroxynitrite, nitric
oxide, and organic solvents as the mechanism of chemical sensitivity in multiple
chemical sensitivity. FASEB J 16:1407-1417.
